 My name is Michel Nadeau. We are Team Tactio Vital from Canada and California. I actually founded a company to do network diagnostics and we were successful in very large networks. The word Tactio is a sense of touch and we decided to make it that word for two reasons. We wanted to design software with no keyboards and no mouse. Just use with the finger, with the simplicity of finger, and that was the beginning of the iPhone, actually, at those times. The other thing is once you take all the information about your body and you bring it into some form of a screen or something, you get more connected to yourself and we thought the sense of touch was actually something interesting. I think mobile health is changing the whole business model. A lot of people see mHealth with all the paradigms of the current healthcare system, which is very curative, very driven on the hospitals and the information that the doctors needed in the hospital to be digitized. I think mHealth is all about providing a totally different experience and reversing all that pyramid with the patient as being the center of this whole new healthcare system. We needed some biosensing technologies to help us. We were working with several popular biosensors for physical activity and all kinds of things and some blood pressure cuffs and all that. But we wanted something a little more closer to the body or maybe within the body or something very, very close to spend a lot more in the chronic diseases area. So far, you know, we have done a lot in a lot of different chronic diseases. You know, busy the hypertension, we've done diabetes management, working on the COPD and CHF. So we're working various chronic diseases one by one. I think for the tricorder to be effective, it needs to be something that can scale to very large population levels to actually achieve enormous outcomes and change healthcare. Our expertise is really in our technologies centered around the scaling, the platform and all the software required for that. Combined together, we have a solution, I think, which is very compelling for a very broad scope of chronic disease management and diagnostics. Thank you.